Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATHE
11976
Alterity Therapeutics
ATHE
$79.2M
| $51.8K | ﹤0.01% |
16,811
-5,333
| -24% | -$20.4K |
|
|
EPSM
11977
Epsium Enterprise
EPSM
$18.9M
| $51.5K | ﹤0.01% |
+25,745
| New | +$294K |
|
11978
CALL
Alector
ALEC
$165M
| $51.3K | ﹤0.01% |
32,900
+16,100
| +96% | +$28.6K |
|
11979
CALL
GrowGeneration
GRWG
$88.9M
| $51.3K | ﹤0.01% |
34,200
-17,400
| -34% | -$28.6K |
|
|
LGPS
11980
LogProstyle Inc
LGPS
$22.2M
| $51.2K | ﹤0.01% |
52,806
+8,122
| +18% | +$8.55K |
|
|
BMNG
11981
PUT
Leverage Shares 2X Long BMNR Daily ETF
BMNG
$40M
| $51.2K | ﹤0.01% |
+805
| New | +$106K |
|
|
RECT
11982
Rectitude Holdings
RECT
$18.6M
| $51K | ﹤0.01% |
+28,997
| New | +$71.3K |
|
11983
CALL
Pliant Therapeutics
PLRX
$65M
| $51K | ﹤0.01% |
41,800
+27,300
| +188% | +$41K |
|
11984
CALL
Treace Medical Concepts
TMCI
$310M
| $51K | ﹤0.01% |
+20,800
| New | +$90.3K |
|
|
WIMI
11985
CALL
WiMi Hologram Cloud
WIMI
$23.7M
| $51K | ﹤0.01% |
21,500
-22,890
| -52% | -$77.7K |
|
11986
Mobix Labs
MOBX
$26.7M
| $50.7K | ﹤0.01% |
+18,973
| New | +$119K |
|
11987
CALL
Atossa Therapeutics
ATOS
$23.8M
| $50.6K | ﹤0.01% |
5,720
+4,040
| +240% | +$51.1K |
|
11988
Context Therapeutics
CNTX
$63.7M
| $50.5K | ﹤0.01% |
34,380
-68,983
| -67% | -$80.6K |
|
11989
CALL
Broadwind
BWEN
$106M
| $50.4K | ﹤0.01% |
17,800
+4,900
| +38% | +$12.9K |
|
|
SNT
11990
Senstar Technologies
SNT
$46.2M
| $50.2K | ﹤0.01% |
10,396
-37,259
| -78% | -$160K |
|
11991
PUT
FingerMotion
FNGR
$17.8M
| $50.1K | ﹤0.01% |
40,700
+19,700
| +94% | +$29.2K |
|
11992
System1
SST
$13.8M
| $50K | ﹤0.01% |
12,759
+2,703
| +27% | +$14K |
|
11993
Cryo-Cell International
CCEL
$29.3M
| $50K | ﹤0.01% |
14,525
+3,127
| +27% | +$13K |
|
11994
PUT
Solana Company
HSDT
$100M
| $49.7K | ﹤0.01% |
+17,200
| New | +$114K |
|
11995
Vivani Medical
VANI
$119M
| $49.7K | ﹤0.01% |
40,409
+22,043
| +120% | +$31.9K |
|
11996
PUT
Protalix BioTherapeutics
PLX
$197M
| $49.7K | ﹤0.01% |
27,600
+11,800
| +75% | +$24.1K |
|
11997
CALL
Fuel Tech
FTEK
$45.2M
| $49.6K | ﹤0.01% |
31,800
-93,100
| -75% | -$205K |
|
11998
CALL
Immunic
IMUX
$191M
| $49.5K | ﹤0.01% |
9,280
+5,200
| +127% | +$38.1K |
|
11999
CVD Equipment Corp
CVV
$56.8M
| $49.3K | ﹤0.01% |
15,940
-25,442
| -61% | -$88.5K |
|
|
BKHAR
12000
Black Hawk Acquisition Corp Rights
BKHAR
| $49.1K | ﹤0.01% |
37,781
-6,559
| -15% | -$9.06K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.